MetaCap

Korsana Biosciences (KRSA) vs First Tracks Biotherapeutics (TRAX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

First Tracks Biotherapeutics is the larger company by market cap ($1.75 billion vs $1.71 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

KRSA+29.29%TRAX+119.16%
+186%+73%-41%
Apr 6, 20261 yearNov 20, 2026
KRSA+84.39%TRAX+77.19%
+111%+36%-39%
Apr 6, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

KRSA versus TRAX key metrics
MetricKRSATRAX
Share price$37.56$41.64
Market cap$1.71B$1.75B
1-day change+5.95%-6.34%
YTD return+322.50%—
1-year return+262.55%—
5-year return-89.05%—
EPS (TTM)$-16.14$-4.71
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.07M—
Revenue growth (YoY)+3.70%—
Net income (latest FY)$-3.53M—
Operating margin-239.78%—
Net margin-170.11%—
52-week high$59.36$54.78
52-week low$7.19$14.72
Distance from 52-week high-36.73%-23.99%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+17.15%+80.52%
Average volume119.71K826.70K
Shares outstanding45.54M42.02M
Employees19104
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Korsana Biosciences

KRSA stock →

Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 19 employees

About First Tracks Biotherapeutics

TRAX stock →

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees

KRSA vs TRAX FAQ

Which is bigger, Korsana Biosciences or First Tracks Biotherapeutics?

First Tracks Biotherapeutics (TRAX) is larger, with a market capitalization of $1.75B compared with $1.71B for Korsana Biosciences (KRSA).

Are Korsana Biosciences and First Tracks Biotherapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons